Moreover, in previous studies, no difference in salivary t-tau and p-tau concentrations was found between AD patients and non-AD controls [11,21], suggesting that these two proteins are not good candidate salivary biomarkers. This evidence concerns the gene MAPT and Alzheimer disease.